DATE OF RELEASE/EXPIRATION The enduring material will be available from September 10, 2021 to September 10, 2022 Jointly provided by Consortium of Multiple Sclerosis Centers (CMSC) and PlatformQ Health Education, LLC (PQHE). CREDIT AVAILABLE Physicians – 0.25 AMA PRA Category 1 Credit(s)™Nurses – 0.25 contact hours of nursing continuing professional development (NCPD)Pharmacists – 0.25 contact …
Continue reading “MANAGEMENT OF MS IN AFRICAN AMERICANS/BLACKS”
DATE OF RELEASE/EXPIRATION The enduring material will be available from September 10, 2021 to September 10, 2022 Jointly provided by Consortium of Multiple Sclerosis Centers (CMSC) and PlatformQ Health Education, LLC (PQHE). CREDIT AVAILABLE Physicians – 0.5 AMA PRA Category 1 Credit(s)™Nurses – 0.5 contact hours of nursing continuing professional development (NCPD)Pharmacists – 0.5 contact …
Continue reading “TREATMENT APPROACHES IN MS: CRITERIA FOR DECISION MAKING”
DATE OF RELEASE/EXPIRATION The enduring material will be available from August 27, 2021 to September 10, 2022 Jointly provided by Consortium of Multiple Sclerosis Centers (CMSC) and PlatformQ Health Education, LLC (PQHE). CREDIT AVAILABLE Physicians – 1.0 AMA PRA Category 1 Credit(s)™Nurses – 1.0 contact hours of nursing continuing professional development (NCPD)Pharmacists – 1.0 contact …
Continue reading “RACIAL AND GENETIC IMPLICATIONS FOR MS TREATMENT SELECTION”
Released on: December 31, 2021 Deadline extended to: June 30, 2023 This activity is jointly provided by The Consortium of Multiple Sclerosis Centers (CMSC) and Catamount Medical Education. This activity is supported by an independent grant from Alexion Pharmaceuticals. Credit Available Physicians— maximum of 0.75 AMA PRA Category 1 Credit(s)™ Nurses— maximum of 0.75 contact …
CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION 1: FUNDAMENTALS OF CANNABIS REISSUANCE DATE: October 31, 2021 VALID FOR CREDIT THROUGH: October 31, 2022 SERIES DESCRIPTION MS health professionals may be involved in the decision-making process about cannabis and provide care to those with MS who use cannabis. However, numerous surveys indicate that …
CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION 2: CANNABIS AS AN HERBAL MEDICINE – EFFICACY/SIDE EFFECT CONSIDERATIONS AND CASE STUDIES REISSUANCE DATE: October 31, 2021 VALID FOR CREDIT THROUGH: October 31, 2022 SERIES DESCRIPTION MS health professionals may be involved in the decision-making process about cannabis and provide care to those with …
CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION 3: PHARMACOLOGY AND INTERACTIONS, TRIAL DATA, DMTs, AND CASE STUDIES REISSUANCE DATE: October 31, 2021 VALID FOR CREDIT THROUGH: October 31, 2022 SERIES DESCRIPTION MS health professionals may be involved in the decision-making process about cannabis and provide care to those with MS who use …
Released: December 1, 2021 Expires: December 1, 2022 An informative webinar designed to meet the educational needs of neurology physicians, nurse practitioners, PAs, pharmacists, and other healthcare professionals involved in the care of patients living with MS. Program Overview This timely webinar provides an overview of the efficacy, safety, side effects, and immune system impact …
December 9, 2021 1:00-2:00pm EST Live, Interactive Webcast! Overview Multiple sclerosis (MS) is an inflammatory disorder of the central nervous system characterized by demyelination and neurodegenerative progression. Most patients with MS experience relapses and remission of neurological symptoms, especially early in the disease course. Advances in understanding of the immune mechanisms that contribute to MS …
Release Date: December 1, 2021 Valid for Credit Through: December 1, 2022 NARCOMS and Other Registries in Multiple Sclerosis: Issues and Insights Ruth Ann Marrie, MD, PhD; Gary R. Cutter, PhD; Robert J. Fox, MD, MSc; Timothy Vollmer, MD; Tuula Tyry, PhD; Amber Salter, PhD Target Audience: The target audience for this activity is physicians, …
Continue reading “IJMSC: NARCOMS and Other Registries in Multiple Sclerosis: Issues and Insights”
CMSC Scholar © 2020 All rights Reserved | Proudly Created by Adapting Social
